Skin Care Drug Co. Timber Gets OK For Ch. 11 Sale To Lender
A Delaware bankruptcy judge on Monday approved dermatology drug developer Timber Pharmaceuticals' plan for a Chapter 11 sale of its assets, with the debtor telling the court it intended to close...To view the full article, register now.
Already a subscriber? Click here to view full article